feedback welcome

Dosulepine-trazodone

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][draft revision]
 
Line 3: Line 3:
| to = trazodone  
| to = trazodone  
| stop =  
| stop =  
-
* '''Before day 1:''' gradually reduce dosage of dosulepine to a maximum of 75 mg/ day, when this dosage is > 75 mg/day.
+
{{stopDosulepine}}
-
* '''Day 1:''' reduce dosage of dosulepine to 25 mg/day.
+
-
* '''Day 8:''' stop administration of dosulepine .
+
| start =  
| start =  
* '''Day 9:''' start administration of trazodone in a dosage of 100-150 mg/day.
* '''Day 9:''' start administration of trazodone in a dosage of 100-150 mg/day.
* '''Day 16:''' increase administration of trazodone.  
* '''Day 16:''' increase administration of trazodone.  
| info =  
| info =  
-
* Occurrence of the serotonin syndrome is theoretically possilble, so caution is necessary.
+
* {{theorSS}}
-
{{review}}
+
 
}}
}}

Current revision as of 12:17, 2 November 2015

dosulepin
Type antidepressant
Group TCA
links
ATC-code N06AA16
PubChem 13473
PubMed dosulepin
Kompas (Dutch) dosulepin
Wikipedia dosulepin
Trazodone
Type Antidepressant
Group other
links
Medscape Trazodone
PubChem 5533
PubMed Trazodone
Kompas (Dutch) Trazodone
Wikipedia Trazodone

Switch medication from dosulepine to trazodone.

Nietinrijdenbord.png Stop dosulepine
Eenrichtingbord.png Start trazodone
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About